Abstract: TH-PO0707
Kidney Failure in Cancer-Related Mortality in the United States: A CDC WONDER Population-Based Analysis, 1999-2024
Session Information
- AKI: Prevention, Diagnostics, and Management
October 22, 2026 | Location: Exhibit Hall A, Convention Center
Abstract Time: 10:00 AM - 12:00 PM
Category: Acute Kidney Injury
- 101 AKI: Epidemiology, Risk Factors, and Prevention
Authors
- Vijayarao, Sree Sindhu, University of Miami Miller School of Medicine, Miami, Florida, United States
- Maqbool, Farkhanda, Bakhtawar Amin Medical and Dental College, Multan, Punjab, Pakistan
- Patel, Divya, Gujarat Medical Education and Research Society, Gandhinagar, GJ, India
- Kuraku, Dileep Raja, Vinnic'kij nacional'nij medicnij universitet imeni Mikoli Pirogova, Vinnytsia, Vinnytsia Oblast, Ukraine
- Keshapogu, Nagarjuna, Vinnic'kij nacional'nij medicnij universitet imeni Mikoli Pirogova, Vinnytsia, Vinnytsia Oblast, Ukraine
- Thiyagarajan, Ragav Vikraman, MAHSA University, Federal Territory of Kuala Lumpur, Malaysia
- Attaluri, Durga Manaswini, Sri Aurobindo Institute of Medical Sciences, Indore, MP, India
- Venkatesh, Karthik Kanna, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, PY, India
- Narla, Sai Jahnu Sree Reddy, Paris Regional Medical Center, Paris, Texas, United States
- Khan, Nabiha, Faisalabad Medical University, Faisalabad, Punjab, Pakistan
- Younas, Kashf, Bakhtawar Amin Medical and Dental College, Multan, Punjab, Pakistan
- Tekuru, Yogesh, Saint Louis University, St. Louis, Missouri, United States
- Vemulapalli, Sai Charan, Our Lady of Fatima University, Valenzuela, NCR, Philippines
- Kalluri, Hara Gopal, Saint Martinus University Faculty of Medicine, Willemstad, Curaçao
- Maqbool, Tehmeena, Bakhtawar Amin Medical and Dental College, Multan, Punjab, Pakistan
Background
Renal failure and Malignant neoplasms are leading causes of premature death worldwide. Their coexistence worsens outcomes, yet population-level mortality trends remain underexplored. This study examines temporal disparities in U.S. mortality from 1999 to 2024.
Methods
We conducted a retrospective CDC WONDER analysis (1999–2024) using ICD-10 codes N17-N19 (Renal Failure) followed by C00-C97( Malignant Neoplasms). Age-adjusted mortality rates (AAMR) were stratified by sex, race, census region, and urbanization. Joinpoint regression calculated Annual Percent Change (APC) and Average Annual Percent Change (AAPC) with p<0.05.
Results
Overall mortality rate rose from 10.27 in 1999 to 12.03 in 2024 with 623,696 deaths. The rate increased non-significantly from 1999–2012 (APC: 0.54, 95% CI: -0.30–1.39), then non-significantly declined from 2012–2016 (APC: -6.91, 95% CI: -14.01–0.79), then significantly rise from 2016–2024 (APC: 4.53*, 95% CI: 2.93–6.15; p<0.001). Mortality was higher in males (15.73) than females (9.29) in 2024. The highest AAMR was among Black populations (18.99, 95% CI: 18.49–19.50), followed by Whites (11.54, 95% CI: 11.40–11.68). Rates peaked at age ≥85 years (100.34). The West had the highest rate (13.11, 95% CI: 12.81–13.40), followed by the South (12.55, 95% CI: 12.27–12.83). AAMR was highest in Non-Core areas (10.82 , 95% CI: 10.34–11.29), followed by Small Metro areas (9.34 , 95% CI: 8.96–9.72).
Conclusion
This study reveals critical research gaps in renal failure and malignant neoplasms mortality trends across age, race, and geography. Urgent, equity-focused prevention strategies are required to dismantle persistent disparities.